Five Year Outcomes with Alemtuzumab Induction Therapy in Elderly Renal Transplant Recipients

被引：0
|
作者：
Casagrande, M. [1 ]
Cunningham, K. [1 ]
Tseng, C. [1 ]
D'Agostino, C. [1 ]
Wong, L. [1 ]
Richardson, C. [1 ]
机构：
[1] Northwestern Mem Hosp, Pharm, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
423
引用
收藏
页码：354 / 355
页数：2
相关论文
共 50 条
  • [1] Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.
    Yakubu, I.
    Masters, B.
    Ravichandran, B.
    Sparkes, T.
    Moss, M.
    Rasetto, F.
    Jonchhe, S.
    Thomas, B.
    Costa, N.
    Leeser, D.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 614
  • [2] Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
    Hurst, Frank P.
    Altieri, Maria
    Nee, Robert
    Agodoa, Lawrence Y.
    Abbott, Kevin C.
    Jindal, Rahul M.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 34 (06) : 534 - 541
  • [3] Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
    Bosch, W.
    Poowanawittayakom, N.
    Chaikriangkrai, K.
    Mendez, J.
    Hellinger, W. C.
    Gonwa, T. A.
    Krishna, M.
    Pungpapong, S.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : E33 - E39
  • [4] Alemtuzumab induction therapy in HIV-positive renal transplant recipients
    Mclean, Florence E.
    Gathogo, Esther
    Goodall, Dawn
    Jones, Rachael
    Kinlcoh, Sabine
    Post, Frank A.
    AIDS, 2017, 31 (07) : 1047 - 1048
  • [5] Transplantation: Alemtuzumab induction is safe for renal transplant recipients
    Myrvang H.
    Nature Reviews Nephrology, 2011, 7 (7) : 362 - 362
  • [6] Desensitization of living donor renal transplant recipients using Rituximab and alemtuzumab induction therapy
    Friedewald, John J.
    Grafals, Monica
    Power, Emily
    Tambur, Anat
    Ramsey, Glenn
    Gallon, Lorenzo
    Leventhal, Joseph
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 354 - 354
  • [7] Alemtuzumab in Elderly Renal Transplant Recipients Is Not Associated With a Poor Outcome
    Moutzouris, D. -A.
    Koizia, L.
    Willicombe, M.
    Corbett, R.
    Duncan, N.
    Galliford, J.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [8] Immunoglobulin induction therapy in renal transplant recipients - five year data of a prospective randomized pilot study
    Bartylak, B.
    Staak, A.
    Renner, F.
    Suesal, C.
    Dietrich, H.
    Rainer, L.
    Padberg, W.
    Opelz, G.
    Weimer, R.
    INTERNIST, 2015, 56 : 11 - 11
  • [9] IMMUNOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT RECIPIENTS - FIVE YEAR DATA OF A PROSPECTIVE RANDOMIZED PILOT STUDY
    Bartylak, B.
    Staak, A.
    Renner, F.
    Suesal, C.
    Dietrich, H.
    Rainer, L.
    Padberg, W.
    Opelz, G.
    Weimer, R.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 22
  • [10] IMMUNOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT RECIPIENTS - FIVE YEAR DATA OF A PROSPECTIVE RANDOMIZED PILOT STUDY
    Weimer, Rolf
    Bartylak, Bogumila
    Staak, Anne
    Renner, Fabrice
    Suesal, Caner
    Dietrich, Hartmut
    Rainer, Lucy
    Padberg, Winfried
    Opelz, Gerhard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
12345